MedPath
HSA Approval

STOCRIN TABLET 600 mg

SIN12064P

STOCRIN TABLET 600 mg

STOCRIN TABLET 600 mg

September 5, 2002

MSD PHARMA (SINGAPORE) PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantMSD PHARMA (SINGAPORE) PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

J05AG03

efavirenz

Manufacturer Information

MSD PHARMA (SINGAPORE) PTE. LTD.

Zhejiang Huahai Pharmaceutical Co., Ltd.

Active Ingredients

EFAVIRENZ

600 mg

Efavirenz

Documents

Package Inserts

1.4.3_Pristine_QRD_SG_Stocrin LFT_May 2022.pdf

Approved: July 27, 2022

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

STOCRIN TABLET 600 mg - HSA Approval | MedPath